ABSCI CORP

Profile

Company Names

ABSCI CORP
ABSCI, LLC

Addresses

101 E. 6TH STREET, SUITE 350, VANCOUVER, WA 98660

101 E. 6TH STREET, SUITE 300, VANCOUVER, WA 98660

4640 SW MACADAM, SUITE 200B, PORTLAND, OR 97239

Phone Numbers

(360) 949-1041
(503) 208-7882

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$221,021,561.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-03-17 
$125,000,000.00 
$125,000,000.00 
$0.00 
Debt 
4
2020-10-19 
$69,999,976.00 
$69,999,976.00 
$0.00 
Equity 
3
2019-12-05 
$10,360,013.00 
$15,000,000.00 
$4,639,987.00 
Equity 
2
2018-05-25 
$12,000,000.00 
$15,000,000.00 
$3,000,000.00 
Equity 
1
2016-04-06 
$3,661,572.00 
$6,000,000.00 
$2,338,428.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PHIL 
 
BARISH 
EXECUTIVE OFFICER, DIRECTOR
ABSCI, LLC
ELI 
 
CASDIN 
DIRECTOR
CASDIN PARTNERS, LP   |  CASDIN PARTNERS OFFSHORE, LTD.   |  CASDIN VENTURE OPPORTUNITIES FUND, L.P.   |  SINGULAR BIO, INC.   |  SEXTON BIOTECHNOLOGIES, INC.   |  C2I GENOMICS, INC.   |  CEDILLA THERAPEUTICS, INC.   |  ABSCI CORP   |  VINETI, INC.   |  CASDIN PRIVATE GROWTH EQUITY FUND, L.P.   |  SOMALOGIC, INC   |  PAIGE.AI, INC.   |  CENTURY THERAPEUTICS, INC.   |  GENOMATICA INC   |  CASDIN PRIVATE GROWTH EQUITY FUND II, L.P.
DANIEL 
 
GOLD 
DIRECTOR
LEVELS BEYOND,INC.   |  MENES FUND LP   |  ABSCI, LLC
ZACH 
 
JONASSON 
DIRECTOR
AUTONOMIC MATERIALS INC   |  ABSCI, LLC   |  ABSCI CORP
SHELLEY 
 
KLASSEN 
EXECUTIVE OFFICER
ABSCI, LLC
BRYAN 
 
LAWLIS 
DIRECTOR
ABSCI, LLC   |  SUTRO BIOPHARMA INC
V. 
BRYAN 
LAWLIS 
DIRECTOR
COHERUS BIOSCIENCES, INC.   |  ABSCI CORP
BRYAN 
 
LAWLISS 
DIRECTOR
ABSCI, LLC
IVANA 
 
MAGOVCEVIC-LIEBISCH 
DIRECTOR
ABSCI CORP   |  VIGIL NEUROSCIENCE, INC.   |  AEGLEA BIOTHERAPEUTICS, INC.
GUSTAVO 
 
MAHLER 
DIRECTOR
ABSCI, LLC   |  ABSCI CORP   |  LIGHTSPEED MICROSCOPY, INC.   |  VERNAL BIOSCIENCES, INC.
SEAN 
 
MCCLAIN 
EXECUTIVE OFFICER, DIRECTOR
ABSCI, LLC   |  ABSCI CORP
LAWRENCE 
 
MCCLURE 
EXECUTIVE OFFICER
ABSCI CORP
KAREN 
 
MCGINNIS 
DIRECTOR
ABSCI CORP
AMRIT 
 
NAGPAL 
DIRECTOR
REDMILE BIOPHARMA INVESTMENTS I, L.P.   |  REDMILE BIOPHARMA INVESTMENTS II, L.P.   |  LIFESPROUT, INC.   |  REDCO I, L.P.   |  ABSCI CORP   |  REDMILE BIOPHARMA INVESTMENTS III, L.P.   |  REDCO II, L.P.   |  REDCO II OFFSHORE FUND, L.P.   |  REDMILE GROWTH INVESTMENTS I, L.P.   |  STAR THERAPEUTICS LLC
ANDREAS 
 
PIHL 
DIRECTOR
ABSCI CORP
GREGORY 
 
SCHIFFMAN 
EXECUTIVE OFFICER
BIOECLIPSE THERAPEUTICS, INC.   |  ABSCI CORP
ZACH 
 
ZACH JONASSON 
DIRECTOR
ABSCI, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-03-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-03-17 
2021-03-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-19 
2021-02-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-19 
2020-10-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-19 
2019-12-19
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2019-12-05 
2018-06-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-25 
2016-04-21
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2016-04-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE